New heart valve study aims to improve treatment for narrowed aortic valve
NCT ID NCT06342635
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new heart valve called Hydra in 50 people with severe aortic stenosis, a condition where the heart's main valve narrows. The goal is to see if the valve is safe and works well for up to one year after a minimally invasive replacement procedure. Researchers will also use CT scans to understand how the valve's shape affects heart rhythm problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Copenhagen University Hospital, Rigshospitalet
RECRUITINGCopenhagen, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single stitch beat a double closure for TAVI patients?
- Can a fitness app boost recovery after heart valve replacement?
- A new heart valve without Open-Heart surgery: can it help High-Risk patients?
- Can a single antiplatelet drug beat aspirin after heart valve replacement?
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Which heart valve works best for small aortic openings? a Head-to-Head trial